A tiny implant, roughly the size of a grain of rice, is currently undergoing trials in Boston. Researchers say the device could slow or even stop the advancement of macular telangiectasia, a condition that gradually impairs vision.
Macular telangiectasia is a rare retinal disorder known for causing progressive loss of sight over time.